223 related articles for article (PubMed ID: 29256037)
1. Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.
Lv TT; Wang P; Guan SY; Li HM; Li XM; Wang B; Pan HF
Ir J Med Sci; 2018 Aug; 187(3):723-730. PubMed ID: 29256037
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis.
Qian J; Wang Y; Huang C; Yang X; Zhao J; Wang Q; Tian Z; Li M; Zeng X
Autoimmun Rev; 2016 Mar; 15(3):250-7. PubMed ID: 26640159
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis.
Wang P; Lv TT; Guan SY; Li HM; Leng RX; Zou YF; Pan HF
Postgrad Med; 2017 Jan; 129(1):126-132. PubMed ID: 27666289
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognosis analysis of systemic lupus erythematosus patients with pulmonary hypertension: A systematic review and meta-analysis.
Yang J; Zhou F; Zhou X; Sun Y; Lun X; Cao J; Fan B
Medicine (Baltimore); 2023 Sep; 102(36):e34947. PubMed ID: 37682181
[TBL] [Abstract][Full Text] [Related]
5. Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis.
Wang P; Mao YM; Zhao CN; Liu LN; Li XM; Li XP; Pan HF
Angiology; 2018 Mar; 69(3):228-235. PubMed ID: 28635303
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.
Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD
Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080
[TBL] [Abstract][Full Text] [Related]
7. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.
Liu Y; Cheng Z; Zha B; Chen X; Gong Z; Ji L; Wei L
Lupus; 2023 Oct; 32(11):1310-1319. PubMed ID: 37699157
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy.
Ruiz-Irastorza G; Garmendia M; Villar I; Egurbide MV; Aguirre C
Autoimmun Rev; 2013 Jan; 12(3):410-5. PubMed ID: 22841984
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis.
Zhao CN; Mao YM; Wang P; Guan SY; Sam NB; Li XM; Wang DG; Pan HF
Rheumatol Int; 2018 Sep; 38(9):1635-1641. PubMed ID: 29845430
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis.
García-Carrasco M; Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Vallejo-Ruiz V; Munguía-Realpozo P; Colombo AL; Cervera R
Autoimmun Rev; 2019 Feb; 18(2):184-191. PubMed ID: 30572140
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Zuily S; Domingues V; Suty-Selton C; Eschwège V; Bertoletti L; Chaouat A; Chabot F; Regnault V; Horn EM; Erkan D; Wahl D
Autoimmun Rev; 2017 Jun; 16(6):576-586. PubMed ID: 28411166
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients.
Kim JS; Kim D; Joo YB; Won S; Lee J; Shin J; Bae SC
Lupus; 2018 Oct; 27(11):1769-1777. PubMed ID: 30028258
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause.
Akdogan A; Kilic L; Dogan I; Okutucu S; Er E; Kaya B; Coplu L; Calguneri M; Tokgozoglu L; Ertenli I
J Clin Rheumatol; 2013 Dec; 19(8):421-5. PubMed ID: 24263143
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic lupus erythematosus.
Shen JY; Chen SL; Wu YX; Tao RQ; Gu YY; Bao CD; Wang Q
Rheumatol Int; 1999; 18(4):147-51. PubMed ID: 10220835
[TBL] [Abstract][Full Text] [Related]
17. Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysis.
Wang J; Qian J; Wang Y; Zhao J; Wang Q; Tian Z; Li M; Zeng X
Lupus; 2017 Nov; 26(13):1390-1400. PubMed ID: 28409522
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension and systemic lupus erythematosus.
Nair SS; Askari AD; Popelka CG; Kleinerman JF
Arch Intern Med; 1980 Jan; 140(1):109-11. PubMed ID: 7352785
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis.
Wu Q; Liu Y; Wang W; Zhang Y; Liu K; Chen SH; Chen B
Front Immunol; 2022; 13():938406. PubMed ID: 35935948
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors.
Gu C; Zhao R; Zhang X; Gu Z; Zhou W; Wang Y; Guo J; Bao Y; Sun C; Dong C; Gao J
Arch Osteoporos; 2019 Dec; 15(1):1. PubMed ID: 31802295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
